Oralair® 300 IR

Oralair® 300 IR

Sublingual tablets for allergen-specific immunotherapy (AIT)

Oralair® 300 IR is a medicinal product used for sublingual allergen-specific immunotherapy in the treatment of allergic rhinitis and rhinoconjunctivitis caused by grass pollen allergy. It is indicated for adults, adolescents, and children from the age of 5 years.

The product contains a standardized mixture of grass pollen allergen extracts and is intended for maintenance therapy following the initial treatment phase. The tablet is administered sublingually, allowing gradual immune tolerance development to the allergens.

Indications

• Allergic rhinitis
• Allergic rhinoconjunctivitis
• Confirmed grass pollen allergy

Method of administration

The tablet is taken once daily and placed under the tongue until completely dissolved. It should not be chewed or swallowed immediately.

Initiation of treatment and the first dose should be supervised by a healthcare professional.

Composition

Standardized allergen extracts of five grass pollens:

• Timothy grass
• Orchard grass
• Perennial ryegrass
• Meadow grass
• Sweet vernal grass

Dosage form

• Sublingual tablets
• Strength: 300 IR
• Pack size: 30 tablets
• Maintenance treatment

Age group

• Adults
• Children and adolescents from 5 years of age

Manufacturer

Stallergenes Greer